Lilly will also pay Akouos' shareholders an additional amount of about $610 million contingent on certain events related to its trials.
(Reporting by Leroy Leo in Bengaluru; Editing by Shinjini Ganguli)
Eli Lilly to buy genetic medicine developer Akouos for $487 million
October 18, 2022 at 07:05 am EDT
Share
(Reuters) - Drugmaker Eli Lilly and Co will acquire genetic medicine developer Akouos Inc in a cash deal worth about $487 million.
Share
